Journal of Artificial Intelligence and Digital Health

Prof. Giuseppe Murdaca is an Associate Professor of Internal Medicine at the University of Genoa, Italy. He holds an MD, a specialization in Internal Medicine, and a PhD in Immunology. His work focuses on immunodeficiencies, autoimmune diseases, biological therapies, immune system dysregulation, and chronic inflammatory diseases. He has an extensive clinical and academic background, serving in teaching, research, and hospital settings. Prof. Murdaca has authored numerous scientific publications in immunology, internal medicine, infectious diseases, and clinical therapeutics, contributing significantly to both clinical practice and medical research.

• Immunology & Clinical Immunodeficiency
• Biological & Immunomodulatory Therapies
• Chronic Inflammatory Diseases

1. Associate Professor of Internal Medicine – University of Genoa

2. Researcher and lecturer in Clinical Immunology and Internal Medicine

3. Author of numerous scientific papers in peer-reviewed journals

4. Contributor to national and international immunology research networks

5. Reviewer for multiple medical journals

1. Use of Artificial Intelligence to Analyze Exposome in Developing Chronic Diseases: A Review of Current Literature. Informatics, 2024 .
2. Monkeypox 2024 Outbreak: Fifty Essential Questions and Answers. Allergy, 2024 .
3. The Effects of Cancer Immunotherapy on Fertility: Focus on Hematological Malignancies. Biomedicines, 2024 .
4. Aromatase Inhibitor–Induced Bone Loss Osteosarcopenia in Older Patients with Breast Cancer: Effects of Denosumab vs. Bisphosphonates. Internal and Emergency Medicine, 2024 .
5. Gender Differences in the Interplay Between Vitamin D and Microbiota in Allergic and Autoimmune Diseases. Biomedicines, 2024;12(5):1023.
6. A Critical View on Autoantibodies in Lupus Nephritis: Concrete Knowledge Based on Evidence. Autoimmunity Reviews, 2024;23(5):103535.
7. Practice Pattern for the Use of Intravenous Iloprost for the Treatment of Peripheral Vasculopathy in Systemic Sclerosis: A Case-Control Study from the Italian National Multicenter “SPRING” Registry. Journal of Scleroderma and Related Disorders, 2024;9(1):38–49.
8. Expression of Epidermal Growth Factor Receptor (EGFR) in Systemic Sclerosis Patients and Gastro-Oesophageal Reflux Disease. Immunology Letters, 2024:106834.
9. Vitamin D in Health and Disease 2.0. Biomedicines, 2024;12(2):324.
10. Does the Impact of COVID-19 on Patients with Systemic Sclerosis Change Over Time? Arthritis Care & Research, 2024;76(1):88–97.
11. Circular RNAs: A New Approach to Multiple Sclerosis. Biomedicines, 2023;11(11):2883.
12. Impact of COVID-19 and Vaccination Campaign on 1,755 Systemic Sclerosis Patients During the First Three Years of the Pandemic. Journal of Translational Autoimmunity, 2023;7:100212.